SkyePharma PLC Rating Reiterated by N+1 Singer (SKP)
SkyePharma PLC (LON:SKP)‘s stock had its “corporate” rating reiterated by analysts at N+1 Singer in a research report issued to clients and investors on Thursday, Analyst Ratings Net reports.
SkyePharma PLC (LON:SKP) opened at 216.00 on Thursday. SkyePharma PLC has a one year low of GBX 37.197 and a one year high of GBX 239.75. The stock’s 50-day moving average is GBX 177.7 and its 200-day moving average is GBX 119.7. The company’s market cap is £99.4 million.
Separately, analysts at Edison Group reiterated a “positive” rating on shares of SkyePharma PLC in a research note on Monday, March 31st.
SkyePharma PLC is a pharmaceutical company. The Company validates drug delivery technologies to develop oral and inhalation pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.